India  

Expert panel recommends dropping ‘clinical trial mode’ tag for Covaxin

IndiaTimes Wednesday, 10 March 2021
In a move likely to boost the use of Bharat Biotech’s anti-Covid vaccine Covaxin, the drug regulator's subject expert committee (SEC) on Wednesday recommended doing away with the “clinical trial mode” for its use and making it a case of regular emergency use authorisation.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

U.S. Securities and Exchange Commission U.S. Securities and Exchange Commission Government agency overseeing stock exchanges

Sec. Buttigieg: Infrastructure has always been a job creator for America [Video]

Sec. Buttigieg: Infrastructure has always been a job creator for America

Transportation Sec. Pete Buttigieg joins CNN’s Alisyn Camerota to breakdown what is in President Biden’s new infrastructure plan.

Credit: Bleacher Report AOL    Duration: 02:38Published
Elon Musk changes his twitter bio to 'Technoking of Tesla', is that his new title?| Oneindia News [Video]

Elon Musk changes his twitter bio to 'Technoking of Tesla', is that his new title?| Oneindia News

Elon Musk has once again amused everyone. Now he isn't just Elon Musk but has a new title. In a filing with the Securities and Exchange Commission, Tesla disclosed that Musk is adding the title of Technoking of Tesla. It also said that Chief Financial Officer Zach Kirkhorn had taken on the title of Master of Coin. Each executive will keep his more standard title as well. #ElonMusk #TechnoKing #Tesla

Credit: Oneindia    Duration: 01:14Published
SEC: Elon Musk officially named 'Technoking of Tesla' [Video]

SEC: Elon Musk officially named 'Technoking of Tesla'

In a filing with the Securities and Exchange Commission, Tesla disclosed that CEO Elon Musk is adding the title of “Technoking of Tesla.” It also said that Chief Financial Officer Zach Kirkhorn had taken on the title of “Master of Coin.” CNN’s Richard Quest and Paul R. La Monica discuss the move by Musk.

Credit: Bleacher Report AOL    Duration: 03:06Published

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Fauci predicts U.S. resumption of J&J vaccine [Video]

Fauci predicts U.S. resumption of J&J vaccine

[NFA] Dr. Anthony Fauci on Sunday predicted that U.S. health regulators will end the temporary pause on distributing Johnson & Johnson's COVID-19 vaccine, adding he expects a decision could come as soon as Friday. Freddie Joyner has more.

Credit: Reuters - Politics    Duration: 01:24Published
Fauci: We'll get Johnson and Johnson vaccine back 'in some manner' [Video]

Fauci: We'll get Johnson and Johnson vaccine back 'in some manner'

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, shares when he expects a decision to be made about the Johnson & Johnson Covid-19 vaccine, predicting the vaccine would come back on the market with restrictions or warnings.

Credit: Bleacher Report AOL    Duration: 02:10Published
Time to put vaccines at medical stores to beat Covid wave? Top doctors answer [Video]

Time to put vaccines at medical stores to beat Covid wave? Top doctors answer

With the second wave of Covid-19 infections putting pressure on India's healthcare infrastructure, top doctors comment on how the government can update its vaccination strategy. Doctors Jalil Parkar and Amit Thadhani spoke on the need to widen the vaccination net, and also include the private sector to a greater degree. Watch the full video for more.

Credit: HT Digital Content    Duration: 03:44Published
'4 people on 1 bed': Patients' relatives on ordeal at Delhi hospitals | Covid [Video]

'4 people on 1 bed': Patients' relatives on ordeal at Delhi hospitals | Covid

Relatives of patients admitted to Delhi hospitals for Covid-19 treatment recounted their ordeal amid an unprecedented surge in cases. The patients' relatives said they found admission after being rejected by multiple hospitals. One of them claimed that 4 people were being housed on a single bed, while another stated that her relative had been asked to lie down on the floor, and was being denied food and water. Delhi saw 25,500+ new Covid cases in 24 hours, the highest single-day surge so far. Watch the full video for more.

Credit: HT Digital Content    Duration: 02:15Published
Germany mourns its 80,000 Covid dead at memorial [Video]

Germany mourns its 80,000 Covid dead at memorial

Germany, represented by Chancellor Angela Merkel and President Frank-Walter Steinmeier, holds a national memorial service in a Berlin concert hall for its nearly 80,000 victims of the coronavirus pandemic.

Credit: euronews (in English)    Duration: 01:00Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Even as Covid vaccine demand rises, firms may take some weeks to up production

Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
IndiaTimes

You Might Like


Related videos from verified sources

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech [Video]

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN..

Credit: ANI     Duration: 01:42Published
They thought they got the Covid-19 vaccine. They were part of a trial instead [Video]

They thought they got the Covid-19 vaccine. They were part of a trial instead

More than a dozen slum residents in Bhopal, India, say they thought they were being vaccinated for Covid-19. They say they later discovered from local activists that some of them hadn’t been given an..

Credit: Bleacher Report AOL     Duration: 03:42Published

Related news from verified sources

No shortage of Covid vaccine doses in any state in India, clarifies health ministry

The Union Health Ministry on Thursday clarified that there is no shortage of Covid-19 vaccine doses in any state in the country so far. Responding to a question...
IndiaTimes

Saudi Arabia makes COVID vaccine mandatory for Haj pilgrims

Saudi Arabia’s Health Ministry has issued an order ruling that only those who have been vaccinated against Covid-19 will be allowed to attend the Haj this...
Zee News Also reported by •IndiaTimes

Iran to get 5 lakh doses of Indian COVID-19 vaccine, first tranche dispatched today

Continuing its vaccine diplomacy, India will send Iran 500,000 doses of Indian covid vaccine COVAXIN, the first tranche of which reached the country on Thursday....
Zee News Also reported by •IndiaTimes